# Evogen, Inc.: Form D filings

Evogen, Inc., a biotechnology company in Lenexa, KS, filed 2 Form D notices with the SEC between 2010 and 2014. The latest, on February 19, 2014, reports $852,420 sold of a $1.6 million offering to 8 investors.

Find out what Evogen, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Evogen%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Evogen%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fevogen-inc-1170875)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Evogen%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Evogen%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fevogen-inc-1170875)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Kansas](https://specstream.ai/data/form-d/state/kansas): 193 rows, by operating companies, filed since November 1, 2024, $9.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/kansas
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 10513 W. 84th Terrace, Lenexa, KS, 64214
- Phone: (913) 312-5676
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1170875

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 19, 2014 | New notice | $1,580,000 | $852,420 | $727,580 | 8 | Jan 21, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1170875/000117087514000002/0001170875-14-000002-index.htm) |
| Jan 25, 2010 | New notice | $2,000,000 | $1,041,322 | $958,678 | 10 | Jan 11, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1170875/000117087510000003/0001170875-10-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Nathan Ledeboer | Director |  |
| Hans Kastensmith | Executive Officer, Director, Promoter |  |
| Richard St. Clair | Executive Officer |  |
| Jonathan Leitersdorf | Director |  |
| Robert Dondes | Executive Officer |  |
| Sean Reineke | Director |  |

[Every Form D from the week of Feb 17, 2014](https://specstream.ai/data/form-d/week/2014-02-17) · [All recent filings in Kansas](https://specstream.ai/data/form-d/state/kansas) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Evogen, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).